List of Tables
    Table 1. Measles Vaccine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Measles Vaccine Market Trends
    Table 3. Measles Vaccine Market Drivers
    Table 4. Measles Vaccine Market Challenges
    Table 5. Measles Vaccine Market Restraints
    Table 6. Global Measles Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Measles Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Measles Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Measles Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Measles Vaccine Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Measles Vaccine Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Measles Vaccine Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Measles Vaccine Sales by Manufacturer, (K MT), 2017-2022
    Table 14. Global Measles Vaccine Sales Share by Manufacturer, 2017-2022
    Table 15. Global Measles Vaccine Price by Manufacturer (2017-2022) & (USD/MT)
    Table 16. Global Measles Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Measles Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Measles Vaccine as of 2021)
    Table 18. Top Players of Measles Vaccine in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Measles Vaccine Product Type
    Table 20. Date of International Manufacturers Enter into Measles Vaccine Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Measles Vaccine Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Measles Vaccine Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Measles Vaccine Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Measles Vaccine Sales by Players, (K MT), 2020, 2021 & 2022
    Table 26. United States Measles Vaccine Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Measles Vaccine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Measles Vaccine Sales in Volume by Region (2017-2022) & (K MT)
    Table 29. Global Measles Vaccine Sales in Volume Forecast by Region (2023-2028) & (K MT)
    Table 30. Global Measles Vaccine Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Measles Vaccine Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Measles Vaccine Sales in Volume by Country (2017-2028) & (K MT)
    Table 33. North America Measles Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Measles Vaccine Sales in Volume by Region (2017-2028) & (K MT)
    Table 35. Asia Pacific Measles Vaccine Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Measles Vaccine Sales in Volume by Country (2017-2028) & (K MT)
    Table 37. Europe Measles Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Measles Vaccine Sales in Volume by Country (2017-2028) & (K MT)
    Table 39. Latin Americaa Measles Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Measles Vaccine Sales in Volume by Country (2017-2028) & (K MT)
    Table 41. Middle East and Africa Measles Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. GSK Corporation Information
    Table 43. GSK Description and Business Overview
    Table 44. GSK Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 45. GSK Measles Vaccine Product
    Table 46. GSK Recent Development
    Table 47. Sanofi-Pasteur Corporation Information
    Table 48. Sanofi-Pasteur Description and Business Overview
    Table 49. Sanofi-Pasteur Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 50. Sanofi-Pasteur Product
    Table 51. Sanofi-Pasteur Recent Development
    Table 52. Merck Corporation Information
    Table 53. Merck Description and Business Overview
    Table 54. Merck Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 55. Merck Product
    Table 56. Merck Recent Development
    Table 57. Novartis Corporation Information
    Table 58. Novartis Description and Business Overview
    Table 59. Novartis Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 60. Novartis Product
    Table 61. Novartis Recent Development
    Table 62. Pfizer Corporation Information
    Table 63. Pfizer Description and Business Overview
    Table 64. Pfizer Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 65. Pfizer Product
    Table 66. Pfizer Recent Development
    Table 67. Serum Institute of India Corporation Information
    Table 68. Serum Institute of India Description and Business Overview
    Table 69. Serum Institute of India Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 70. Serum Institute of India Product
    Table 71. Serum Institute of India Recent Development
    Table 72. China National Biotech Group Corporation Information
    Table 73. China National Biotech Group Description and Business Overview
    Table 74. China National Biotech Group Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 75. China National Biotech Group Product
    Table 76. China National Biotech Group Recent Development
    Table 77. Bavarian Nordic Corporation Information
    Table 78. Bavarian Nordic Description and Business Overview
    Table 79. Bavarian Nordic Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 80. Bavarian Nordic Product
    Table 81. Bavarian Nordic Recent Development
    Table 82. Emergent Biosolutions Corporation Information
    Table 83. Emergent Biosolutions Description and Business Overview
    Table 84. Emergent Biosolutions Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 85. Emergent Biosolutions Product
    Table 86. Emergent Biosolutions Recent Development
    Table 87. Medimmune Corporation Information
    Table 88. Medimmune Description and Business Overview
    Table 89. Medimmune Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 90. Medimmune Product
    Table 91. Medimmune Recent Development
    Table 92. Johnson & Johnson Corporation Information
    Table 93. Johnson & Johnson Description and Business Overview
    Table 94. Johnson & Johnson Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 95. Johnson & Johnson Product
    Table 96. Johnson & Johnson Recent Development
    Table 97. CSL Limited Corporation Information
    Table 98. CSL Limited Description and Business Overview
    Table 99. CSL Limited Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 100. CSL Limited Product
    Table 101. CSL Limited Recent Development
    Table 102. Key Raw Materials Lists
    Table 103. Raw Materials Key Suppliers Lists
    Table 104. Measles Vaccine Customers List
    Table 105. Measles Vaccine Distributors List
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Measles Vaccine Product Picture
    Figure 2. Global Measles Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Measles Vaccine Market Size 2017-2028 (US$ Million)
    Figure 4. Global Measles Vaccine Sales 2017-2028 (K MT)
    Figure 5. United States Measles Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Measles Vaccine Market Size 2017-2028 (US$ Million)
    Figure 7. United States Measles Vaccine Sales 2017-2028 (K MT)
    Figure 8. United States Measles Vaccine Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Measles Vaccine Market Share in Global, in Volume (K MT) 2017-2028
    Figure 10. Measles Vaccine Report Years Considered
    Figure 11. Product Picture of Mumps Measles Rubella Vaccine, Live (MMR-II)
    Figure 12. Product Picture of Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
    Figure 13. Global Measles Vaccine Market Share by Type in 2022 & 2028
    Figure 14. Global Measles Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Measles Vaccine Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Measles Vaccine Sales by Type (2017-2028) & (K MT)
    Figure 17. Global Measles Vaccine Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Measles Vaccine Price by Type (2017-2028) & (USD/MT)
    Figure 19. United States Measles Vaccine Market Share by Type in 2022 & 2028
    Figure 20. United States Measles Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Measles Vaccine Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Measles Vaccine Sales by Type (2017-2028) & (K MT)
    Figure 23. United States Measles Vaccine Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Measles Vaccine Price by Type (2017-2028) & (USD/MT)
    Figure 25. Product Picture of Children
    Figure 26. Product Picture of Adults
    Figure 27. Global Measles Vaccine Market Share by Application in 2022 & 2028
    Figure 28. Global Measles Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 29. Global Measles Vaccine Sales Market Share in Value by Application (2017-2028)
    Figure 30. Global Measles Vaccine Sales by Application (2017-2028) & (K MT)
    Figure 31. Global Measles Vaccine Sales Market Share in Volume by Application (2017-2028)
    Figure 32. Global Measles Vaccine Price by Application (2017-2028) & (USD/MT)
    Figure 33. United States Measles Vaccine Market Share by Application in 2022 & 2028
    Figure 34. United States Measles Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. United States Measles Vaccine Sales Market Share in Value by Application (2017-2028)
    Figure 36. United States Measles Vaccine Sales by Application (2017-2028) & (K MT)
    Figure 37. United States Measles Vaccine Sales Market Share in Volume by Application (2017-2028)
    Figure 38. United States Measles Vaccine Price by Application (2017-2028) & (USD/MT)
    Figure 39. North America Measles Vaccine Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 40. North America Measles Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 41. U.S. Measles Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Canada Measles Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Europe Measles Vaccine Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 44. Europe Measles Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. Germany Measles Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. France Measles Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. U.K. Measles Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Italy Measles Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Russia Measles Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Asia-Pacific Measles Vaccine Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 51. Asia-Pacific Measles Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 52. China Measles Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Japan Measles Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. South Korea Measles Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. India Measles Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Australia Measles Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Taiwan Measles Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Indonesia Measles Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Thailand Measles Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Malaysia Measles Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Philippines Measles Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Latin America Measles Vaccine Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 63. Latin America Measles Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 64. Mexico Measles Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Brazil Measles Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Argentina Measles Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Middle East & Africa Measles Vaccine Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 68. Middle East & Africa Measles Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Turkey Measles Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Saudi Arabia Measles Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. UAE Measles Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Measles Vaccine Value Chain
    Figure 73. Measles Vaccine Production Process
    Figure 74. Channels of Distribution
    Figure 75. Distributors Profiles
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed